151 related articles for article (PubMed ID: 28738453)
1. [Promoting hepatitis B elimination and laying emphasis on its economics evaluation].
Zhang SX
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):841-844. PubMed ID: 28738453
[TBL] [Abstract][Full Text] [Related]
2. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
Liu J; Liu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
[TBL] [Abstract][Full Text] [Related]
3. [Development of Markov models for economics evaluation of strategies on hepatitis B vaccination and population-based antiviral treatment in China].
Yang PC; Zhang SX; Sun PP; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):845-851. PubMed ID: 28738454
[No Abstract] [Full Text] [Related]
4. Requirements for global elimination of hepatitis B: a modelling study.
Nayagam S; Thursz M; Sicuri E; Conteh L; Wiktor S; Low-Beer D; Hallett TB
Lancet Infect Dis; 2016 Dec; 16(12):1399-1408. PubMed ID: 27638356
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
[No Abstract] [Full Text] [Related]
6. Countdown to 2030: eliminating hepatitis B disease, China.
Liu J; Liang W; Jing W; Liu M
Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
8. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
[TBL] [Abstract][Full Text] [Related]
9. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
Mangen MJ; Stibbe H; Urbanus A; Siedenburg EC; Waldhober Q; de Wit GA; van Steenbergen JE;
Vaccine; 2017 May; 35(24):3215-3221. PubMed ID: 28483198
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and prevention of hepatitis B virus infection in China.
Lu FM; Li T; Liu S; Zhuang H
J Viral Hepat; 2010 Mar; 17 Suppl 1():4-9. PubMed ID: 20586928
[TBL] [Abstract][Full Text] [Related]
11. Progress in the prevention and control of viral hepatitis type B: closing remarks.
Rizzetto M; Zanetti AR
J Med Virol; 2002 Jul; 67(3):463-6. PubMed ID: 12116047
[TBL] [Abstract][Full Text] [Related]
12. Control of hepatitis B in China: prevention and treatment.
Wang Y; Jia J
Expert Rev Anti Infect Ther; 2011 Jan; 9(1):21-5. PubMed ID: 21171874
[TBL] [Abstract][Full Text] [Related]
13. Achieving ultimate control of hepatitis B infection in China: progress and challenges.
Jia JD; Yao GB
J Viral Hepat; 2010 Mar; 17 Suppl 1():2-3. PubMed ID: 20586927
[No Abstract] [Full Text] [Related]
14. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
Danielsson N; Fakakovikaetau T; Szegedi E
Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
[TBL] [Abstract][Full Text] [Related]
15. Universal hepatitis B vaccination.
Kretzschmar M; de Wit A
Lancet Infect Dis; 2008 Feb; 8(2):85-7; author reply 90. PubMed ID: 18222156
[No Abstract] [Full Text] [Related]
16. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
17. The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges.
Averhoff F; Kolwaite A; Ward JW
Vaccine; 2013 Dec; 31 Suppl 9():J5-7. PubMed ID: 23623862
[No Abstract] [Full Text] [Related]
18. Healthy adult vaccination: An urgent need to prevent hepatitis B in China.
Qiu Y; Ren J; Yao J
Hum Vaccin Immunother; 2016 Mar; 12(3):773-8. PubMed ID: 26337328
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.
Rots NY; Wijmenga-Monsuur AJ; Luytjes W; Kaaijk P; de Graaf TW; van der Zeijst BA; Boog CJ
Vaccine; 2010 Jan; 28(4):893-900. PubMed ID: 19932217
[TBL] [Abstract][Full Text] [Related]
20. [National hepatitis B vaccination closer to implementation, but not soon enough: recommendations from the Dutch Health Council].
Gunning-Schepers LJ; Houweling H
Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1572-3. PubMed ID: 11525094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
